Home HOME General Physiology and Biophysics 2015 General Physiology and Biophysics Vol.34, No.4, p.393–398, 2015

Journal info


Quarterly, 80 pp. per issue
Founded: 1982
ISSN  1338-4325 (online)

Published in English

Aims and Scope
Editorial Info
Abstracting and Indexing
Submission Guidelines

Select Journal







Webshop Cart

Your Cart is currently empty.


General Physiology and Biophysics Vol.34, No.4, p.393–398, 2015

Title: Lymph node mapping using quantum dot-labeled polymersomes
Author: Rumiana Bakalova, Zhivko Zhelev, Biliana Nikolova, Shuhei Murayama, Desislava Lazarova, Iana Tsoneva, Ichio Aoki

Abstract: The present study was designed to investigate whether poly-ion complex hollow vesicles (polymersomes), based on chemically-modified chitosan, are appropriate for lymph node mapping in the context of their application in the development of theranostic nanosized drug delivery systems (nano-DDS). The experiments were performed on Balb/c nude mice (colon cancer-grafted). The mice were subjected to anesthesia and quantum dot (QD705)-labeled polymersomes (d~120 nm) were injected intravenously via the tail vein. The optical imaging was carried out on Maestro EX Imaging System (excitation filter: 435–480 nm; emission filter: 700 nm). A strong fluorescent signal, corresponding to QD705 fluorescence, was detected in the lymph nodes, as well as in the tumor. A very weak fluorescent signal was found in the liver area. The half-life of QD705-labelled polymersomes was 6 ± 2 hours in the bloodstream and 11 ± 3 hours in the lymph nodes. The data suggest that polymersomes are very promising carriers for lymph node mapping using QD as a contrast agent. They are useful matrix for development of nano-formulations with theranostic capabilities.

Keywords: Polymersomes — Quantum dot — Lymph nodes — Imaging
Published online: 21-Sep-2015
Year: 2015, Volume: 34, Issue: 4 Page From: 393, Page To: 398
doi:10.4149/gpb_2015007


download file



© AEPress s.r.o
Copyright notice: For any permission to reproduce, archive or otherwise use the documents in the ELiS, please contact AEP.